loadpatents
name:-0.012359142303467
name:-0.010052919387817
name:-0.0020458698272705
Zoghbi; Huda Y. Patent Filings

Zoghbi; Huda Y.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zoghbi; Huda Y..The latest application filed is for "compositions and methods for modulating mecp2 expression".

Company Profile
1.8.9
  • Zoghbi; Huda Y. - Houston TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods for modulating MECP2 expression
Grant 11,129,844 - Freier , et al. September 28, 2
2021-09-28
Ataxia therapeutic compositions and methods
Grant 10,973,812 - Orr , et al. April 13, 2
2021-04-13
Compositions and Methods for Modulating MECP2 Expression
App 20200078389 - Freier; Susan M. ;   et al.
2020-03-12
Methods For Modulating Mecp2 Expression
App 20180044673 - Zoghbi; Huda Y. ;   et al.
2018-02-15
Ataxia Therapeutic Compositions And Methods
App 20170252334 - Orr; Harry T. ;   et al.
2017-09-07
Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
Grant 7,470,673 - Zoghbi , et al. December 30, 2
2008-12-30
Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
Grant 7,442,688 - Zoghbi , et al. October 28, 2
2008-10-28
Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
Grant 7,053,200 - Zoghbi , et al. May 30, 2
2006-05-30
Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
Grant 6,838,444 - Zoghbi , et al. January 4, 2
2005-01-04
Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
App 20040237127 - Zoghbi, Huda Y. ;   et al.
2004-11-25
Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
App 20040231009 - Zoghbi, Huda Y. ;   et al.
2004-11-18
Method of screening Rett syndrome by detecting a mutation in MECP2
Grant 6,709,817 - Zoghbi , et al. March 23, 2
2004-03-23
Transgenic mammals expressing polyglutamine
App 20040045046 - Zoghbi, Huda Y. ;   et al.
2004-03-04
Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
App 20020192665 - Zoghbi, Huda Y. ;   et al.
2002-12-19
Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
App 20010032339 - Zoghbi, Huda Y. ;   et al.
2001-10-18
Chaperone Suppression Of Ataxin-1 Aggregation And Altered Subcellular Proteasome Localization Imply Protein Misfilind In Sca1
App 20010027182 - ZOGHBI, HUDA Y. ;   et al.
2001-10-04
Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
Grant 5,741,645 - Orr , et al. April 21, 1
1998-04-21
Company Registrations
NCAGE Code53AH2ZOGHBI HUDA Y
CAGE Code53AH2ZOGHBI, HUDA Y
SEC0001681643Zoghbi Huda Y

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed